StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.75−0.12 (-14.00%)

Close on Nov 12, 2026Market cap $34.60MP/E –Yield –

OS Therapies statistics

53 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$34.60M
$280.48M
Enterprise Value
$34.39M
$148.62M

Share statisticsIndustry

Shares Change (YoY)
77.8%
10.9%
Shares Change (QoQ)
15.3%
0.51%
Float
40M
49M
Shares Held by Insiders
13.5%
12.1%
Shares Held by Institutions
6.28%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
-2.15%
-0.76%
Short % of Float
6.92%
9.04%
Short % of Shares Outstanding
5.98%
6.30%
Days to Cover
7.73
5.13

Stock price statisticsIndustry

52-Week High
$2.25
–
52-Week Low
$0.58
–
20-Day Moving Average
$1.14
–
50-Day Moving Average
$1.45
–
200-Day Moving Average
$1.54
–
Average True Range (14)
$0.13
–
Price Change (1 Week)
-23.5%
1.51%
Price Change (1 Month)
-46.0%
-2.35%
Price Change (3 Months)
-53.7%
-21.1%
Price Change (6 Months)
-60.1%
-22.6%
Price Change (YTD)
-46.4%
-22.6%
Price Change (1 Year)
-60.3%
-20.7%
Average Volume (10 Days)
942,493
–
Average Volume (20 Days)
651,646
–
Average Volume (90 Days)
603,681
–
Relative Volume
2.21
0.79
Relative Strength Index (14)
16.6
44.7
Volatility (1 Year)
76.9%
80.4%
Beta (5 Years)
0.26
1.07

Returns on capitalIndustry

Return on Assets (ROA)
-389.6%
-40.6%

Financial positionIndustry

Current Ratio
0.18
3.30
Quick Ratio
0.01
2.42

EfficiencyIndustry

Profits Per Employee
-$39.37K
-$683.67K
Employee Count
1,000
75
WACC
7.48%
10.1%

Income statement (TTM)Industry

Operating Income
-$37.61M
-$20.99M
Net Income
-$39.37M
-$21.61M
EBITDA
-$37.11M
-$16.85M
EPS (Diluted)
-$1.07
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$205.04K
$17.46M
Net Cash Per Share
$0.00
$0.72
Equity (Book Value)
-$11.91M
$53.27M
Book Value Per Share
-$0.26
$1.50
Tangible Book Value
-$18.17M
$26.82M
Working Capital
-$17.00M
$79.47M

Cash flow (TTM)Industry

Operating Cash Flow
-$18.53M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-113.8%
-20.8%

Scores and fair valueIndustry

Altman Z-Score
-25.80
0.30
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodOSTXS&P 500DifferenceOSTX per yearS&P 500 per year
1 month-51.9%-2.7%−49.2 pts
3 months-53.4%-1.7%−51.7 pts
Year to date-46.4%+11.9%−58.3 pts
1 year-60.9%+12.0%−72.9 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M OSTX shares were sold short on Oct 30, 2026, down 2.1% from the previous report, or 6.92% of the shares available to trade. At recent volumes it would take 7.7 days to buy them back. Over the last 20 sessions, 45.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,760,127-2.1%357,2477.7
Oct 15, 20262,820,664+8.7%963,5262.9
Sep 30, 20262,595,455+22.7%668,1823.9
Sep 15, 20262,114,665-23.4%839,0522.5
Aug 31, 20262,760,835+6.9%419,3986.6
Aug 14, 20262,583,033-6.9%282,8819.1
Jul 31, 20262,773,058+5.3%324,7128.5
Jul 15, 20262,633,212+16.9%1,015,9232.6
Jun 30, 20262,251,861+10.8%894,5252.5
Jun 15, 20262,031,661+22.6%642,0863.2
May 29, 20261,657,466+26.0%819,2732.0
May 15, 20261,315,663-5.0%595,4542.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?